Johnson & Johnson (JNJ) |
|
159.29 -0.97 (-0.61%)
|
09-26 15:09 |
|
Open: |
159.81 |
Pre. Close: |
160.26 |
|
High:
|
160.08 |
Low:
|
158.86 |
|
Volume:
|
2,753,800 |
Market Cap:
|
383,572(M) |
|
|
|
Technical analysis |
as of: 2023-09-26 2:50:12 PM |
|
Short-term rate:
|
 |
| Stoxline posted a SELL today, same as yesterday. Downward movement continues. |
|
Mid-term rate:
|
|
| Target: |
Six months: 191.35  One year: 196.03 |
| Support: |
Support1: 157.35 Support2: 130.91 |
| Resistance: |
Resistance1: 163.83 Resistance2: 167.83 |
| Pivot: |
161.53 |
| Moving Average: |
MA(5): 160.87 MA(20): 161.69
MA(100): 163.36 MA(250): 165.26 |
| MACD: |
MACD(12,26): -1.6 Signal(9): -1.5 |
| Stochastic oscillator: |
%K(14,3): 32.6 %D(3): 43.1 |
| RSI: |
RSI(14): 36.2 |
| 52-week: |
High: 181.03 Low: 150.11 |
| Average Vol(K): |
3-Month: 23,422 (K) 10-Days: 6,241 (K) |
|
Price, moving averages and Bollinger Bands |
|
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.[ JNJ ] has closed above bottom band by 13.6%. Bollinger Bands are 35.9% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
|
|
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
160.54 - 161.84 |
161.84 - 162.72 |
|
Low:
|
155.98 - 157.44 |
157.44 - 158.42 |
|
Close:
|
158.34 - 160.61 |
160.61 - 162.14 |
|
Company Description |
|
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO, NEUTROGENA, and OGX brands; TYLENOL acetaminophen products; SUDAFED cold, flu, and allergy products; BENADRYL and ZYRTEC allergy products; MOTRIN IB ibuprofen products; NICORETTE smoking cessation products; and PEPCID acid reflux products. It also offers STAYFREE and CAREFREE sanitary pads; o.b. tampons; adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand. It serves general public, retail outlets, and distributors. The company's Pharmaceutical segment offers products for rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; HIV/AIDS and COVID-19 infectious diseases; mood disorders, neurodegenerative disorders, and schizophrenia; prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; thrombosis, diabetes and macular degeneration; and pulmonary arterial hypertension. This segment serves retailers, wholesalers, distributors, hospitals, and healthcare professionals directly for prescription use. Its MedTech segment provides electrophysiology products to treat cardiovascular diseases; neurovascular care products to treat hemorrhagic and ischemic stroke; orthopaedics products in support of hips, knees, trauma, spine, sports, and other; advanced and general surgery solutions that focus on breast aesthetics, ear, nose, and throat procedures; and disposable contact lenses and ophthalmic products related to cataract and laser refractive surgery under the ACUVUE brand. This segment serves wholesalers, hospitals, and retailers. The company was founded in 1886 and is based in New Brunswick, New Jersey. |
Headline News |
Tue, 26 Sep 2023
At least one seriously injured in Johnson County county crash - KCRG
Tue, 26 Sep 2023
BET co-founder Sheila Johnson talks about her 'Walk Through Fire' in new memoir - ABC News
Tue, 26 Sep 2023
Earvin "Magic" Johnson hosts community discussion about RSV prevention in the Bronx - WABC-TV
Tue, 26 Sep 2023
Rethinking Zach Johnson, the unlikeliest Ryder Cup captain - The Athletic
Tue, 26 Sep 2023
Jenna Johnson's Son Is the Spitting Image of Dad with 'Slick' Hair - PEOPLE
Tue, 26 Sep 2023
Millionaire Bryan Johnson Takes '111 Pills Daily', Wears 'Jet Pack' Below His Belt To Stay Young: Report - NDTV
|
Financial Analysis |
| Price to Book Value: |
Outperform |
| P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
| Price to Earnings: |
Outperform |
| PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
| Discounted cash flow: |
Outperform |
| DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
| Return on Assets: |
Neutral |
| ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
| Return on Equity: |
Outperform |
| ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
| Debt to Equity: |
Outperform |
| evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NYSE |
| Sector: Healthcare |
| Industry: Drug Manufacturers—General |
| Shares Out. |
2,410 (M) |
| Shares Float |
2,600 (M) |
|
% Held by Insiders
|
0.1 (%) |
|
% Held by Institutions
|
70.7 (%) |
|
Shares Short
|
32,860 (K) |
|
Shares Short P.Month
|
25,730 (K) |
Stock Financials |
|
EPS
|
4.92 |
|
EPS Est Next Qtl
|
0 |
|
EPS Est This Year
|
0 |
|
EPS Est Next Year
|
0 |
|
Book Value (p.s.)
|
28.92 |
|
Profit Margin (%)
|
13.3 |
|
Operating Margin (%)
|
27.6 |
|
Return on Assets (ttm)
|
9.1 |
|
Return on Equity (ttm)
|
17 |
|
Qtrly Rev. Growth
|
6.3 |
|
Gross Profit (p.s.)
|
26.53 |
|
Sales Per Share
|
40.56 |
|
EBITDA (p.s.)
|
14.23 |
|
Qtrly Earnings Growth
|
8.8 |
|
Operating Cash Flow
|
19,070 (M) |
|
Levered Free Cash Flow
|
21,510 (M) |
Stock Valuations |
|
PE Ratio
|
32.25 |
|
PEG Ratio
|
2.7 |
|
Price to Book value
|
5.49 |
|
Price to Sales
|
3.92 |
|
Price to Cash Flow
|
20.09 |
Stock Dividends |
|
Dividend
|
1.19 |
|
Forward Dividend
|
0 |
|
Dividend Yield
|
0.7% |
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
Your Ad Here
|
|
